GAVI & Vaccines
The 1st Global Summit on Women Cancers in Africa occurred September 1st-2nd in 2010 at the United Nations Conference Centre in Addis Ababa, Ethiopia. Representatives for the Global Alliance for Vaccines and Immunizations (GAVI) were present to discuss Human Papilloma Virus (HPV) vaccine support for African countries. Partnering with GAVI would be a very beneficial, due to the absence of routine cervical cancer screening in many countries. Representatives from pharmaceutical companies, Glaxo-Smith Kline, Merck, and Qiagen, were also present. The following year (2011), GAVI reported their success in negotiating a reduced cost per dose for HPV vaccines. By 2012, 3.9 million girls had received the HPV vaccine.
The World Health Organization estimates that 325 million people worldwide are living with Hepatitis B and Hepatitis C infections. Hepatitis B virus is the leading cause of liver cancer.
In Uganda, the Maternal and Neonatal Tetanus Elimination campaign worked to eliminate neonatal tetanus. In 2017 the WHO estimated over 30,000 neonatal death, worldwide, were due to tetanus.